| __timestamp | Alpine Immune Sciences, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 581800000 |
| Thursday, January 1, 2015 | 16054000 | 671900000 |
| Friday, January 1, 2016 | 23316000 | 876700000 |
| Sunday, January 1, 2017 | 10626000 | 857900000 |
| Monday, January 1, 2018 | 28970000 | 822200000 |
| Tuesday, January 1, 2019 | 35847000 | 778200000 |
| Wednesday, January 1, 2020 | 27185000 | 512600000 |
| Friday, January 1, 2021 | 58742000 | 681000000 |
| Saturday, January 1, 2022 | 70243000 | 662200000 |
| Sunday, January 1, 2023 | 80904000 | 910700000 |
Igniting the spark of knowledge
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Viatris Inc. and Alpine Immune Sciences, Inc. have demonstrated contrasting yet intriguing R&D investment strategies.
Viatris Inc., a global healthcare company, has consistently invested in R&D, with expenses peaking in 2023 at approximately 910 million USD. This represents a 56% increase from 2014, underscoring their commitment to advancing healthcare solutions.
Conversely, Alpine Immune Sciences, Inc., a smaller biotech firm, has shown a remarkable 563% increase in R&D spending from 2014 to 2023, reaching around 81 million USD. This surge highlights their aggressive pursuit of innovative therapies.
These trends reflect the diverse strategies within the industry, where both established giants and nimble newcomers play pivotal roles in shaping the future of medicine.
R&D Spending Showdown: Sanofi vs Viatris Inc.
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
Research and Development Investment: Genmab A/S vs Alpine Immune Sciences, Inc.
Viatris Inc. or Ascendis Pharma A/S: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and HUTCHMED (China) Limited
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs Novavax, Inc.